Kazuyoshi Saito Selected Research

Interstitial Lung Diseases (Interstitial Lung Disease)

12/2020	Severe pulmonary arterial hypertension and interstitial pneumonia related to systemic lupus erythematosus successfully treated with mycophenolate mofetil: A novel case report.
1/2019	Fifty-Two-Week Results of Clinical and Imaging Assessments of a Patient with Rheumatoid Arthritis Complicated by Systemic Sclerosis with Interstitial Pneumonia and Type 1 Diabetes despite Multiple Disease-Modifying Antirheumatic Drug Therapy That Was Successfully Treated with Baricitinib: A Novel Case Report.
1/2005	Human urinary trypsin inhibitor bolus infusion improved severe interstitial pneumonia in mixed connective tissue disease.
6/2002	[A case of rheumatoid arthritis with secondary amyloidosis in urinary bladder].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kazuyoshi Saito Research Topics

Disease

71	Rheumatoid Arthritis 01/2022 - 05/2003
20	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2021 - 10/2003
16	Neoplasms (Cancer) 01/2022 - 01/2002
8	Inflammation (Inflammations) 01/2019 - 12/2006
7	Autoimmune Diseases (Autoimmune Disease) 01/2021 - 02/2002
7	Rheumatic Diseases (Rheumatism) 01/2020 - 01/2007
7	Carcinoma (Carcinomatosis) 01/2006 - 07/2002
6	Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) 07/2022 - 12/2007
6	Stomach Neoplasms (Stomach Cancer) 01/2022 - 11/2002
6	Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia) 01/2020 - 03/2009
6	Infections 08/2012 - 02/2004
5	Vasculitis (Vasculitides) 01/2022 - 12/2003
5	Neoplasm Metastasis (Metastasis) 10/2005 - 04/2002
4	Fever (Fevers) 01/2022 - 06/2009
4	Immunoglobulin G4-Related Disease 01/2022 - 12/2012
4	Arthritis (Polyarthritis) 01/2021 - 02/2004
4	Interstitial Lung Diseases (Interstitial Lung Disease) 12/2020 - 06/2002
3	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2022 - 01/2021
3	Pneumonia (Pneumonitis) 01/2022 - 03/2009
3	Heart Failure 12/2014 - 11/2009
3	Lung Diseases (Lung Disease) 02/2014 - 11/2012
3	Opportunistic Infections (Opportunistic Infection) 11/2012 - 01/2005
3	Synovitis 06/2012 - 05/2003
2	Mixed Connective Tissue Disease (MCTD) 11/2022 - 01/2005
2	Pulmonary Arterial Hypertension 11/2022 - 12/2020
2	Spontaneous Remission 01/2022 - 01/2022
2	Disease Progression 01/2022 - 04/2011
2	Microscopic Polyangiitis 01/2022 - 01/2021
2	Exanthema (Rash) 01/2022 - 01/2019
2	Fibrosis (Cirrhosis) 01/2022 - 10/2009
2	Connective Tissue Diseases (Connective Tissue Disease) 01/2021 - 11/2016
2	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2021 - 01/2020
2	Adenoma (Adenomas) 01/2020 - 02/2004
2	Behcet Syndrome (Behcet's Syndrome) 01/2019 - 08/2009
2	Lupus Nephritis 01/2017 - 01/2017
2	Bone Fractures (Bone Fracture) 11/2016 - 11/2008
2	Bone Resorption 11/2016 - 08/2004
2	Osteoporosis 11/2016 - 01/2012
2	Pathologic Processes 11/2016 - 11/2013
2	Dermatomyositis (Dermatopolymyositis) 01/2012 - 01/2008
2	Drug-Related Side Effects and Adverse Reactions 10/2011 - 01/2007
2	Atrophy 05/2011 - 10/2009
2	Body Weight (Weight, Body) 04/2011 - 08/2002
2	Sjogren's Syndrome (Sjogren Syndrome) 10/2009 - 12/2003

Drug/Important Bio-Agent (IBA)

16	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019 - 01/2008
14	Infliximab (Remicade)FDA Link 12/2017 - 01/2007
13	tocilizumab (atlizumab)FDA Link 01/2021 - 01/2009
12	Biological ProductsIBA 01/2018 - 02/2004
11	Methotrexate (Mexate)FDA LinkGeneric 01/2022 - 01/2007
10	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021 - 08/2002
10	Etanercept (Enbrel)FDA Link 09/2016 - 01/2009
9	Tumor Necrosis Factor InhibitorsIBA 01/2021 - 07/2011
9	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 03/2018 - 12/2004
8	GlucocorticoidsIBA 01/2022 - 01/2004
8	Abatacept (Orencia)FDA Link 01/2018 - 01/2014
7	Prednisolone (Predate)FDA LinkGeneric 01/2020 - 02/2004
6	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2021 - 10/2003
6	Pharmaceutical PreparationsIBA 01/2020 - 01/2007
6	CytokinesIBA 01/2020 - 08/2002
6	Monoclonal AntibodiesIBA 01/2020 - 01/2008
5	Adalimumab (Humira)FDA Link 09/2020 - 06/2012
5	Antirheumatic Agents (DMARD)IBA 01/2019 - 02/2004
5	Biomarkers (Surrogate Marker)IBA 11/2016 - 01/2009
4	SteroidsIBA 07/2022 - 10/2003
4	Rituximab (Mabthera)FDA Link 01/2022 - 01/2007
4	Fluorouracil (Carac)FDA LinkGeneric 03/2003 - 11/2002
3	InterferonsIBA 01/2020 - 06/2012
3	Interleukin-17 (Interleukin 17)IBA 01/2020 - 03/2011
3	AutoantibodiesIBA 01/2019 - 01/2009
3	alfacalcidolIBA 11/2016 - 01/2004
3	Interleukin-6 (Interleukin 6)IBA 01/2014 - 01/2009
3	Etidronic Acid (HEDP)FDA LinkGeneric 01/2012 - 01/2004
2	AntibodiesIBA 11/2022 - 01/2019
2	Intravenous Immunoglobulins (IVIG)FDA Link 05/2022 - 11/2021
2	Immunoglobulin G (IgG)IBA 01/2022 - 08/2018
2	Certolizumab Pegol FDA Link 01/2021 - 01/2021
2	Thymidine Monophosphate (TMP)IBA 01/2020 - 01/2017
2	Trimethoprim (Proloprim)FDA LinkGeneric 01/2020 - 01/2017
2	Sulfamethoxazole FDA LinkGeneric 01/2020 - 01/2017
2	CT-P13IBA 03/2017 - 01/2015
2	Diphosphonates (Bisphosphonates)IBA 11/2016 - 11/2008
2	3-benzoyl dopamine (MBDA)IBA 11/2016 - 05/2015
2	Alendronate (Alendronate Sodium)FDA LinkGeneric 11/2016 - 11/2008
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2016 - 06/2009
2	Proteins (Proteins, Gene)FDA Link 12/2014 - 12/2007
2	tofacitinibIBA 05/2014 - 06/2012
2	Syk KinaseIBA 01/2012 - 06/2009
2	Brain-Derived Neurotrophic Factor (BDNF)IBA 06/2011 - 03/2010
2	Dopamine (Intropin)FDA LinkGeneric 03/2011 - 02/2009
2	Adenosine Triphosphate (ATP)IBA 04/2010 - 12/2002
2	Tacrolimus (Prograf)FDA LinkGeneric 03/2010 - 04/2007

Therapy/Procedure

37	Therapeutics 01/2022 - 11/2002
6	Drug Therapy (Chemotherapy) 01/2022 - 01/2003
4	Laparotomy 07/2006 - 01/2003
4	Pancreaticoduodenectomy 01/2006 - 08/2002
4	Intravenous Infusions 03/2003 - 06/2002
3	Lymph Node Excision (Lymph Node Dissection) 01/2006 - 07/2002
2	Remission Induction 01/2022 - 12/2017
2	Traction 05/2016 - 02/2003
2	Biological Therapy 02/2014 - 11/2012